DZ2948A1 - Dérivé d'indole nouveau, procédé pour sa préparation et compositions pharmaceutiques le contenant. - Google Patents

Dérivé d'indole nouveau, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Info

Publication number: DZ2948A1
Authority: DZ; Algeria
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; indole derivative; new indole
Prior art date: 1998-11-27

Application number

DZ990248A

Other languages

English (en)

French (fr)

Inventor

Christopher Lan Dallman

Ronald James Ogilvie

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-27

Filing date

1999-11-24

Publication date

2004-03-15

1999-11-24 Application filed by Pfizer filed Critical Pfizer

2004-03-15 Application granted granted Critical

2004-03-15 Publication of DZ2948A1 publication Critical patent/DZ2948A1/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Lasers (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DZ990248A 1998-11-27 1999-11-24 Dérivé d'indole nouveau, procédé pour sa préparation et compositions pharmaceutiques le contenant. DZ2948A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9825988.0A GB9825988D0 (en)	1998-11-27	1998-11-27	Indole derivatives

Publications (1)

Publication Number	Publication Date
DZ2948A1 true DZ2948A1 (fr)	2004-03-15

Family

ID=10843140

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990248A DZ2948A1 (fr)	1998-11-27	1999-11-24	Dérivé d'indole nouveau, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Country Status (53)

Country	Link
US (2)	US20020013358A1 (xx)
EP (1)	EP1135381B1 (xx)
JP (1)	JP3777094B2 (xx)
KR (1)	KR100413739B1 (xx)
CN (1)	CN1131860C (xx)
AP (1)	AP2001002149A0 (xx)
AR (1)	AR024232A1 (xx)
AT (1)	ATE273300T1 (xx)
AU (1)	AU754731B2 (xx)
BG (1)	BG64706B1 (xx)
BR (1)	BR9915692A (xx)
CA (1)	CA2352392C (xx)
CO (1)	CO5150178A1 (xx)
CR (1)	CR6325A (xx)
CU (1)	CU23269A3 (xx)
CZ (1)	CZ295472B6 (xx)
DE (1)	DE69919388T2 (xx)
DK (1)	DK1135381T3 (xx)
DZ (1)	DZ2948A1 (xx)
EA (1)	EA003551B1 (xx)
EE (1)	EE04914B1 (xx)
ES (1)	ES2224701T3 (xx)
GB (1)	GB9825988D0 (xx)
GC (1)	GC0000113A (xx)
GE (1)	GEP20043183B (xx)
GT (1)	GT199900202A (xx)
HK (1)	HK1042898B (xx)
HN (1)	HN1999000196A (xx)
HR (1)	HRP20010398B1 (xx)
HU (1)	HUP0105308A3 (xx)
ID (1)	ID28802A (xx)
IL (1)	IL141663A (xx)
IS (1)	IS2238B (xx)
MA (1)	MA26708A1 (xx)
MY (1)	MY124078A (xx)
NO (1)	NO320798B1 (xx)
NZ (1)	NZ510055A (xx)
OA (1)	OA11671A (xx)
PA (1)	PA8485701A1 (xx)
PE (1)	PE20001299A1 (xx)
PL (1)	PL194503B1 (xx)
PT (1)	PT1135381E (xx)
RS (1)	RS50002B (xx)
SI (1)	SI1135381T1 (xx)
SK (1)	SK285774B6 (xx)
SV (1)	SV1999000204A (xx)
TN (1)	TNSN99221A1 (xx)
TR (1)	TR200101493T2 (xx)
TW (1)	TWI246512B (xx)
UA (1)	UA68402C2 (xx)
UY (2)	UY25823A1 (xx)
WO (1)	WO2000032589A1 (xx)
ZA (1)	ZA200102681B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0018968D0 (en) *	2000-08-02	2000-09-20	Pfizer Ltd	Particulate composition
WO2004089365A1 (en)	2003-04-11	2004-10-21	Pfizer Limited	Pharmaceutical combination comprising eletriptan and sodium bicarbonate
GB0317229D0 (en) *	2003-07-23	2003-08-27	Pfizer Ltd	Improved process
US6927296B2 (en)	2003-07-23	2005-08-09	Pfizer Inc.	Process
EP2093225A1 (en)	2007-05-01	2009-08-26	Plus Chemicals B.V.	Process for preparing crystalline eletriptan hydrobromide form ß
EP2038273A1 (en) *	2007-05-29	2009-03-25	Plus Chemicals B.V.	A process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole
US20100285075A1 (en) *	2007-12-17	2010-11-11	Actavis Group Ptc Ehf	Novel Hemioxalate Salt of Eletriptan
US20120027816A1 (en) *	2009-02-25	2012-02-02	Actavis Group Ptc Ehf	Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
WO2010116386A2 (en) *	2009-04-08	2010-10-14	Biophore India Pharmaceuticals Pvt. Ltd.	Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
WO2011089614A1 (en) *	2010-01-19	2011-07-28	Sms Pharmaceuticals Limited	PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM
WO2014063752A1 (en)	2012-10-26	2014-05-01	Synthon Bv	Process for making crystalline form alpha of eletriptan hydrobromide
CN103893112A (zh) *	2012-12-31	2014-07-02	重庆圣华曦药业股份有限公司	氢溴酸依来曲普坦注射液
CN107954947A (zh) *	2016-10-14	2018-04-24	北京莱瑞森医药科技有限公司	沃替西汀氢溴酸盐晶型c及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3952741A (en)	1975-01-09	1976-04-27	Bend Research Inc.	Controlled release delivery system by an osmotic bursting mechanism
FR2624732B1 (fr)	1987-12-21	1991-02-15	Synthelabo	Formulation pharmaceutique a liberation prolongee
US5474784A (en)	1990-03-02	1995-12-12	British Technology Group Limited	Dispensing device
EP0592438B1 (en)	1990-10-15	1997-08-27	Pfizer Inc.	Indole derivatives
US5545644A (en) *	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5464633A (en)	1994-05-24	1995-11-07	Jagotec Ag	Pharmaceutical tablets releasing the active substance after a definite period of time
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
GB9510223D0 (en)	1995-05-20	1995-07-19	Pfizer Ltd	Therapeutic agent
TW448172B (en) *	1996-03-08	2001-08-01	Pharmacia & Upjohn Co Llc	Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
US5998462A (en) *	1996-12-16	1999-12-07	Allelix Biopharmaceuticals Inc.	5-alkyl indole compounds
GB9704498D0 (en) *	1997-03-05	1997-04-23	Glaxo Wellcome Spa	Chemical compound
AU724728B2 (en)	1997-07-03	2000-09-28	Pfizer Inc.	Pharmaceutical compositions containing eletriptan hemisulphate and caffeine

1998
- 1998-11-27 GB GBGB9825988.0A patent/GB9825988D0/en not_active Ceased
1999
- 1999-01-11 UA UA2001053569A patent/UA68402C2/uk unknown
- 1999-11-01 KR KR10-2001-7006605A patent/KR100413739B1/ko not_active IP Right Cessation
- 1999-11-01 EE EEP200100285A patent/EE04914B1/xx not_active IP Right Cessation
- 1999-11-01 AP APAP/P/2001/002149A patent/AP2001002149A0/en unknown
- 1999-11-01 DE DE69919388T patent/DE69919388T2/de not_active Expired - Fee Related
- 1999-11-01 EA EA200100297A patent/EA003551B1/ru not_active IP Right Cessation
- 1999-11-01 DK DK99949292T patent/DK1135381T3/da active
- 1999-11-01 GE GEAP19995913A patent/GEP20043183B/en unknown
- 1999-11-01 PL PL99347928A patent/PL194503B1/pl unknown
- 1999-11-01 ID IDW00200101132A patent/ID28802A/id unknown
- 1999-11-01 SK SK699-2001A patent/SK285774B6/sk unknown
- 1999-11-01 TR TR2001/01493T patent/TR200101493T2/xx unknown
- 1999-11-01 OA OA1200100103A patent/OA11671A/en unknown
- 1999-11-01 WO PCT/IB1999/001754 patent/WO2000032589A1/en active IP Right Grant
- 1999-11-01 RS YUP-188/01A patent/RS50002B/sr unknown
- 1999-11-01 CN CN998135798A patent/CN1131860C/zh not_active Expired - Fee Related
- 1999-11-01 AT AT99949292T patent/ATE273300T1/de not_active IP Right Cessation
- 1999-11-01 AU AU62253/99A patent/AU754731B2/en not_active Ceased
- 1999-11-01 EP EP99949292A patent/EP1135381B1/en not_active Expired - Lifetime
- 1999-11-01 IL IL14166399A patent/IL141663A/en not_active IP Right Cessation
- 1999-11-01 NZ NZ510055A patent/NZ510055A/en unknown
- 1999-11-01 CA CA002352392A patent/CA2352392C/en not_active Expired - Fee Related
- 1999-11-01 BR BR9915692-0A patent/BR9915692A/pt not_active Application Discontinuation
- 1999-11-01 CZ CZ20011839A patent/CZ295472B6/cs not_active IP Right Cessation
- 1999-11-01 ES ES99949292T patent/ES2224701T3/es not_active Expired - Lifetime
- 1999-11-01 SI SI9930633T patent/SI1135381T1/xx unknown
- 1999-11-01 JP JP2000585231A patent/JP3777094B2/ja not_active Expired - Fee Related
- 1999-11-01 HU HU0105308A patent/HUP0105308A3/hu unknown
- 1999-11-01 PT PT99949292T patent/PT1135381E/pt unknown
- 1999-11-02 TW TW088119069A patent/TWI246512B/zh not_active IP Right Cessation
- 1999-11-09 HN HN1999000196A patent/HN1999000196A/es unknown
- 1999-11-18 PA PA19998485701A patent/PA8485701A1/es unknown
- 1999-11-23 PE PE1999001178A patent/PE20001299A1/es not_active Application Discontinuation
- 1999-11-24 DZ DZ990248A patent/DZ2948A1/xx active
- 1999-11-24 GC GCP1999381 patent/GC0000113A/xx active
- 1999-11-24 CO CO99074057A patent/CO5150178A1/es unknown
- 1999-11-24 TN TNTNSN99221A patent/TNSN99221A1/fr unknown
- 1999-11-24 MA MA25854A patent/MA26708A1/fr unknown
- 1999-11-25 MY MYPI99005153A patent/MY124078A/en unknown
- 1999-11-25 AR ARP990106025A patent/AR024232A1/es not_active Application Discontinuation
- 1999-11-26 GT GT199900202A patent/GT199900202A/es unknown
- 1999-11-26 SV SV1999000204A patent/SV1999000204A/es not_active Application Discontinuation
- 1999-11-29 UY UY25823A patent/UY25823A1/es unknown
- 1999-11-29 US US09/450,462 patent/US20020013358A1/en not_active Abandoned
- 1999-11-30 UY UY25825A patent/UY25825A1/es unknown
2001
- 2001-02-27 IS IS5868A patent/IS2238B/is unknown
- 2001-03-13 CU CU20010065A patent/CU23269A3/es unknown
- 2001-03-14 CR CR6325A patent/CR6325A/xx not_active Application Discontinuation
- 2001-04-02 ZA ZA200102681A patent/ZA200102681B/xx unknown
- 2001-05-23 BG BG105539A patent/BG64706B1/bg unknown
- 2001-05-24 HR HR20010398 patent/HRP20010398B1/xx not_active IP Right Cessation
- 2001-05-25 NO NO20012584A patent/NO320798B1/no unknown
2002
- 2002-06-11 HK HK02104379.1A patent/HK1042898B/zh not_active IP Right Cessation
2003
- 2003-02-27 US US10/376,385 patent/US7238723B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HRP20010398A2 (en)	2002-06-30
TR200101493T2 (tr)	2002-02-21
JP3777094B2 (ja)	2006-05-24
EA200100297A1 (ru)	2001-08-27
IL141663A (en)	2004-05-12
CN1131860C (zh)	2003-12-24
TNSN99221A1 (fr)	2005-11-10
HK1042898B (zh)	2004-10-08
EE04914B1 (et)	2007-10-15
AR024232A1 (es)	2002-09-25
AU6225399A (en)	2000-06-19
NO20012584D0 (no)	2001-05-25
BG105539A (en)	2001-12-29
CZ20011839A3 (cs)	2001-10-17
PA8485701A1 (es)	2000-09-29
EP1135381A1 (en)	2001-09-26
HN1999000196A (es)	2005-11-26
AP2001002149A0 (en)	2001-06-30
ATE273300T1 (de)	2004-08-15
CO5150178A1 (es)	2002-04-29
CA2352392A1 (en)	2000-06-08
PT1135381E (pt)	2004-10-29
SV1999000204A (es)	2000-10-16
TWI246512B (en)	2006-01-01
SK6992001A3 (en)	2002-01-07
CU23269A3 (es)	2008-04-09
MA26708A1 (fr)	2004-12-20
UY25823A1 (es)	2001-08-27
NO320798B1 (no)	2006-01-30
IS2238B (is)	2007-05-15
IS5868A (is)	2001-02-27
DE69919388T2 (de)	2005-09-29
IL141663A0 (en)	2002-03-10
EA003551B1 (ru)	2003-06-26
EP1135381B1 (en)	2004-08-11
GC0000113A (en)	2005-06-29
GB9825988D0 (en)	1999-01-20
KR100413739B1 (ko)	2004-01-03
GT199900202A (es)	2001-05-19
HUP0105308A3 (en)	2003-01-28
ID28802A (id)	2001-07-05
GEP20043183B (en)	2004-02-25
JP2002531449A (ja)	2002-09-24
PE20001299A1 (es)	2000-12-01
ZA200102681B (en)	2002-07-02
AU754731B2 (en)	2002-11-21
PL194503B1 (pl)	2007-06-29
DK1135381T3 (da)	2004-11-15
NO20012584L (no)	2001-07-27
WO2000032589A1 (en)	2000-06-08
BG64706B1 (bg)	2005-12-30
SI1135381T1 (en)	2004-10-31
HK1042898A1 (en)	2002-08-30
CN1328554A (zh)	2001-12-26
UY25825A1 (es)	2000-08-21
UA68402C2 (en)	2004-08-16
YU18801A (sh)	2003-07-07
CA2352392C (en)	2006-01-24
BR9915692A (pt)	2001-08-14
US20050131237A1 (en)	2005-06-16
CR6325A (xx)	2008-07-02
NZ510055A (en)	2004-11-26
KR20010080594A (ko)	2001-08-22
HRP20010398B1 (en)	2004-12-31
MY124078A (en)	2006-06-30
HUP0105308A2 (hu)	2002-05-29
US7238723B2 (en)	2007-07-03
US20020013358A1 (en)	2002-01-31
CZ295472B6 (cs)	2005-08-17
PL347928A1 (en)	2002-04-22
SK285774B6 (sk)	2007-08-02
ES2224701T3 (es)	2005-03-01
OA11671A (en)	2005-01-12
DE69919388D1 (de)	2004-09-16
EE200100285A (et)	2002-08-15
RS50002B (sr)	2008-09-29

Publication	Publication Date	Title
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26526A1 (fr)	2004-12-20	Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
CH689805A8 (fr)	2000-02-29	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2303A1 (fr)	2002-12-28	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2227A1 (fr)	2002-12-25	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2523A1 (fr)	2003-02-01	Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
MA26638A1 (fr)	2004-12-20	Derives d'isothiazole nouveaux, procede pour leur preparation et compoositions pharmaceutiques les contenant
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ3045A1 (fr)	2004-03-27	Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.